Nemaura Medical Inc (NASDAQ:NMRD), a UK-based company focused on diabetes, announced Monday that it is planning to launch a digital healthcare subscription service in the US under the brand name proBEAT.
The company said that proBEAT is expected to be available without the need for a prescription and appeal to a broad range of adults encompassing pre-diabetic and Type 2 diabetics - 88 million and 26 million people, respectively - as well as those seeking to lose weight and have a healthier lifestyle.
Nemaura said proBEAT can help users improve their knowledge of how a range of lifestyle, dietary and health and wellbeing factors impact their sugar levels by acting like a black box flight recorder.
“Big data about the multitude of factors that affect glucose levels will be gathered from all users and employed in developing and subsequently ‘fine-tuning’ predictive algorithms and artificial intelligence-based feedback and prompts,” the company said in a statement.
“These will then be able to both educate and provide motivational tools to the user to encourage them to lead a healthier lifestyle.”
Nemaura said it is now prioritizing launch plans for its proBEAT digital health platform in the US and is considering various options to expedite the launch, including partnering with multi-national companies.
Nemaura said it intends to market proBEAT as a general wellness product per the US Food and Drug Administration’s (FDA) rules.
General wellness products outlined in FDA guidance are those which have either:
- An intended use that relates to maintaining or encouraging a general state of health or a healthy activity
- Or intended use that relates the role of a healthy lifestyle with helping to reduce the risk or impact of certain chronic diseases or disease conditions and where it is well understood and accepted that healthy lifestyle choices may play an important role in health outcomes for the disease or condition
The company also plans to launch its sugarBEAT continuous glucose monitor in the US. SugarBEAT consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter, with an app displaying glucose readings every five minutes for up to 24 hours.
Contact the author: [email protected]
Follow him on Twitter @PatrickMGraham